SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-16-119351
Filing Date
2016-05-10
Accepted
2016-05-09 18:28:43
Documents
68
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a16-6523_110q.htm 10-Q 888731
2 EX-31.1 a16-6523_1ex31d1.htm EX-31.1 10312
3 EX-31.2 a16-6523_1ex31d2.htm EX-31.2 10326
4 EX-32.1 a16-6523_1ex32d1.htm EX-32.1 6667
5 EX-32.2 a16-6523_1ex32d2.htm EX-32.2 6686
  Complete submission text file 0001104659-16-119351.txt   4771333

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT supn-20160331.xml EX-101.INS 1078100
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT supn-20160331.xsd EX-101.SCH 38440
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT supn-20160331_cal.xml EX-101.CAL 63153
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT supn-20160331_def.xml EX-101.DEF 109194
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT supn-20160331_lab.xml EX-101.LAB 386004
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT supn-20160331_pre.xml EX-101.PRE 264194
Mailing Address 1550 E GUDE DR ROCKVILLE MD 20850
Business Address 1550 E GUDE DR ROCKVILLE MD 20850 301-838-2500
SUPERNUS PHARMACEUTICALS INC (Filer) CIK: 0001356576 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: 10-Q | Act: 34 | File No.: 001-35518 | Film No.: 161633122
SIC: 2834 Pharmaceutical Preparations